Global Retirement Partners’s NRX Pharmaceuticals NRXP Stock Holding History

Global Retirement Partners’s Portfolio NRXP Stock Details NRXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$107K	Buy	+39,300	New	+$105K	﹤0.01%	1872

Other funds holding NRXP

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

OWMIAS

One Wealth Management Investment & Advisory Services Miami Beach, Florida $95.3M AUM 25.31% 1-Year Est. Return

Global Retirement Partners's NRXP Position: Q4 2025 in Review

Global Retirement Partners opened a new position in NRX Pharmaceuticals (NRXP) in Q4 2025: 39,300 shares worth $107K. The stake represents ﹤0.01% of the portfolio and ranks #1872 among its holdings.

28 funds tracked by Wall St. Rank hold NRXP as of Q4 2025.

Global Retirement Partners held 39,300 shares of NRX Pharmaceuticals worth $107K as of Q4 2025.
NRX Pharmaceuticals was a new Global Retirement Partners position in Q4 2025.
NRX Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #1872 holding.
28 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.